Why PTN? Palatin Technologies, Inc. Analysis, Price & AI Insights | Whystock
PTN
$19.30-0.70 (-3.50%)
Market OpenUpdated 11:16 AM EDT
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.